SCHEMBL3092964

SCHEMBL3092964

CCNCc1ccc(Cl)c(C(C)(C)O[SiH2]C(C)(C)C)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 4/20 0.43
HTR1D P28221 4/20 0.43
HTR2A P28223 4/20 0.43
HTR7 P34969 4/20 0.43
HTR2B P41595 4/20 0.43
HTR5A P47898 4/20 0.43
HTR2C P28335 3/20 0.43
HTR6 P50406 3/20 0.43
HTR1B P28222 3/20 0.43
PYCR1 P32322 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
TSHR P16473 2/20 0.33
IDO1 P14902 2/20 0.33
PDE2A O00408 4/20 0.32
CCR5 P51681 1/20 0.32
ALOX15 P16050 1/20 0.31
HTR1E P28566 1/20 0.31
MCHR1 Q99705 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3085748 0.87 HTR1A (0.44) HTR1AHTR1DHTR2AHTR7HTR2B
SCHEMBL3093509 0.86 HTR7 (0.41) HTR1AHTR1DHTR2AHTR7HTR2B
SCHEMBL1751424 0.86 CYP1A2 (0.36) HTR1AHTR1DHTR2AHTR7HTR2B
SCHEMBL3085955 0.85 PLA2G1B (0.34) HTR1AHTR1DHTR2AHTR7HTR2B
SCHEMBL3088565 0.84 PRMT5 (0.47) MEN1KMT2ACYP2D6CYP2C9CYP2C19
SCHEMBL1752274 0.81 TSHR (0.43) SMN1; SMN2TSHR
SCHEMBL1750280 0.81 TSHR (0.58) SMN1; SMN2TSHR
SCHEMBL1751533 0.81 TSHR (0.45) SMN1; SMN2KMT2ATSHR
SCHEMBL1751327 0.81 KCNH2 (0.38) SMN1; SMN2MEN1KMT2ATSHR
SCHEMBL1751846 0.80 CSNK2A1 (0.39) PYCR1IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100324052-A1 NOVEL PIPERIDINE CARBOXYLIC ACID AMINE DERIVATIVES BEZENCON OLIVIER 2010-12-23 US disclosed
US-7799805-B2 Piperidine carboxylic acid amide derivatives ACTELION PHARMACEUTICALS LTD. (CH) 2010-09-21 US disclosed
US-20080214598-A1 Novel Piperidine Carboxylic Acid Amide Derivatives ACTELION PHARMACEUTICALS LTD (CH) 2008-09-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080214598-A1 Novel Piperidine Carboxylic Acid Amide Derivatives REN, ACE, AGTR2 HTR1A 3090/4885HTR1D 2095/4885HTR2A 2555/4885
US-20100324052-A1 NOVEL PIPERIDINE CARBOXYLIC ACID AMINE DERIVATIVES REN, ACE, AGTR2 HTR1A 1917/4885HTR1D 1188/4885HTR2A 1616/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.